References
- Liu JD, Tai CJ, Chang CC, Lin YH, Hsu CH. FDG-PET in a patient with gastric MALT lymphoma. Acta Oncol 2006; 45: 750–2
- Rodriguez M, Ahlström H, Sundin A, Rehn S, Sundström C, Hagberg H, et al. [18F] FDG PET in gastric Non-Hodgkin's lymphoma. Acta Oncol 1997; 36: 577–84
- Hoffmann M, Kletter K, Diemling M, Becherer A, Pfeffel F, Petkov V, et al. Positron emission tomography with fluorine-18-2-fluoro-deoxyglucose (F18-FDG) dose not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 1999; 10: 1185–9
- Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: A report of 42 cases. Ann Oncol 2005; 16: 473–80
- Hoffmann M, Wöhrer S, Becherer A, Chott A, Streubel B, Kletter K, et al. F18-Floro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: Histology makes the difference. Ann Oncol 2006; 17: 1761–5
- Thieblemont G, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002; 87: 105–11
- Holm L, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601–4
- Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, et al. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985; 76: 1085–90
- Derringer GA, Thompson LDR, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: A clinicopathologic study of 108 cases. Am J Surg Pathol 2000; 24: 623–39
- Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006; 15: 2069–77
- Sasai K, Yamabe H, Haga H, Tsutsui K, Dodo Y, Ishigaki T, et al. Non-Hodgkin's lymphoma of the thyroid–a clinical study of twenty-two cases. Acta Oncol 1996; 35: 457–62
- Chen YK, Chen YL, Cheng RH, Yeh CL, Lee CC, Hsu CH. The significance of FDG uptake in bilateral thyroid glands. Nucl Med Commun 2007; 28: 117–22
- Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007; 48: 896–901
- Schmid DT, Kneifel S, Stoeckli SJ, Padberg BC, Merrill G, Goerres GW. Increased F18-FDG uptake mimicking thyroid cancer in a patient with Hashimoto's thyroiditis. Eur Radiol 2003; 13: 2119–21
- Chander S, Zingas AP, Bloom DA, Zak IT, Joyrich RN, Getzen TM. Positron emission tomography in primary thyroid lymphoma. Clin Nucl Med 2004; 29: 572–3
- Puget G, Trampal C, Calvo N, Carrera MJ, Conangla M, Sitges-Serra A, et al. Thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma concurrently diagnosed with a diffuse large B cell lymphoma localized in the neck. Leuk Lymphoma 2007; 48: 425–7
- Lin EC. FDG PET/CT for assessing therapy response in primary thyroid lymphoma. Clin Nucl Med 2007; 32: 152–3
- Mikosch P, Würtz FG, Gallowitsch HJ, Kresnik E, Lind P. F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid. Wien Med Wochenschr 2003; 153: 89–92
- Androulaki A, Syriou V, Lazaris AC, Paterakis T, Pikazis D, Papathomas T, et al. Maltomas of the thyroid and Sjögren's syndrome in a woman with Hashimoto's thyroiditis. Endocr Pathol 2006; 17: 89–94
- Marchesi M, Biffoni M, Biancari F. False-positive finding on F18-FDG PET after chemotherapy for primary diffuse large B-cell lymphoma of the thyroid: A case report. Jpn J Clin Oncol 2004; 34: 280–1